Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morey A Blinder

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Clinical Chemistry|December 31, 2009
CommentaryMorey A Blinder
Hematology Reports|January 9, 2015
Exertional sickling: questions and controversyMorey A Blinder, Sarah Russel
Leukemia & Lymphoma|April 25, 2007
(18)F-FDG-PET-facilitated diagnosis of lymphoma presenting with fever of unknown origin and cold agglutinationMaxwell M Krem, Lihua Pan, Morey A Blinder
American Journal of Hematology|November 22, 2007
Reticulocyte hemoglobin contentAlan E Mast, Morey A Blinder, Dennis J Dietzen
American Journal of Hematology|June 10, 2009
Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literatureHuichung T Ling, Joshua J Field, Morey A Blinder
Pharmacotherapy|October 27, 2006
Immunosuppressive therapy for acute porphyria: safety and efficacy in a patient with bone marrow failureJoshua J Field, Leonard Giannone, Monica Bessler, et al.
Journal of Shoulder and Elbow Surgery|February 6, 2007
Shoulder arthroplasty in sickle cell patients with humeral head avascular necrosisMichelle W Lau, Morey A Blinder, Kimberly Williams, et al.
Blood|February 7, 2002
Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiencyAlan E Mast, Morey A Blinder, Qing Lu, et al.
The Journal of Emergency Medicine|April 26, 2015
Age-Related Emergency Department Reliance in Patients with Sickle Cell DiseaseMorey A Blinder, Mei Sheng Duh, Medha Sasane, et al.
Pediatric Blood & Cancer|January 22, 2013
Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costsMorey A Blinder, Francis Vekeman, Medha Sasane, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinical Chemistry|December 31, 2009
CommentaryMorey A Blinder
Hematology Reports|January 9, 2015
Exertional sickling: questions and controversyMorey A Blinder, Sarah Russel
Leukemia & Lymphoma|April 25, 2007
(18)F-FDG-PET-facilitated diagnosis of lymphoma presenting with fever of unknown origin and cold agglutinationMaxwell M Krem, Lihua Pan, Morey A Blinder
American Journal of Hematology|November 22, 2007
Reticulocyte hemoglobin contentAlan E Mast, Morey A Blinder, Dennis J Dietzen
American Journal of Hematology|June 10, 2009
Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literatureHuichung T Ling, Joshua J Field, Morey A Blinder
Pharmacotherapy|October 27, 2006
Immunosuppressive therapy for acute porphyria: safety and efficacy in a patient with bone marrow failureJoshua J Field, Leonard Giannone, Monica Bessler, et al.
Journal of Shoulder and Elbow Surgery|February 6, 2007
Shoulder arthroplasty in sickle cell patients with humeral head avascular necrosisMichelle W Lau, Morey A Blinder, Kimberly Williams, et al.
Blood|February 7, 2002
Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiencyAlan E Mast, Morey A Blinder, Qing Lu, et al.
The Journal of Emergency Medicine|April 26, 2015
Age-Related Emergency Department Reliance in Patients with Sickle Cell DiseaseMorey A Blinder, Mei Sheng Duh, Medha Sasane, et al.
Pediatric Blood & Cancer|January 22, 2013
Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costsMorey A Blinder, Francis Vekeman, Medha Sasane, et al.
Pageof 2